Potential of the proteasomal inhibitor MG-312 as an anticancer agent, alone and in combination

Anticancer Research

Volumn 21, Issue 6 A, 2001, Pages 3941-3947

  Banerjee, Debabrata ^a   Liefshitz, Anna ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Apoptosis; Cyt C; p53

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN B1; CYCLIN DEPENDENT KINASE; CYCLINE; DOXORUBICIN; ETOPOSIDE; MG 312; PROTEASOME INHIBITOR; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CELL FUNCTION; COLONY FORMATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; STEM CELL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL DIVISION; COLONY-FORMING UNITS ASSAY; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DOXORUBICIN; DRUG SYNERGISM; ETOPOSIDE; G1 PHASE; HEMATOPOIETIC STEM CELLS; HUMANS; K562 CELLS; LEUPEPTINS; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; S PHASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035572083     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Caspases: Intracellular signalling by proteolysis
2. Apoptosis induction resulting from proteasome inhibition
3. p53 status and the efficacy of cancer therapy in vivo
4. Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies
5. How proteolysis drives the cell cycle
6. In vivo inhibition of cyclin B degradation and induction of cell cycle arrest in mammalian cells by the neutral cysteine protease inhibitor, N-acetylleucylleucylnorleucinal
7. p53-dependent induction of apoptosis by proteasome inhibitors
8. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
9. p53 dependent apoptosis modulates the cytotoxicity of anticancer agents
10. p53 mutations in human cancers
11. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
12. p53, apoptosis, and chemosensitivity
13. Activation of the cell death program by inhibition of proteasome function
14. Proteasome inhibitors induce apoptosis in glucocorticoid resistant chronic leukemic lymphocytes
15. Dysregulation of apoptosis in cancer
16. An essential role for NFkB in human CD34+bone marrow cell survival